Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | UNK | — |
Twinrix late 4th dose on the rapid schedule; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 03-JAN-2024, lot no 58160-0815-52), Twinrix (received 2nd dose on 10-JAN-2024, lot no 58160-0815-52) and Twinrix (received 3rd dose on 12-FEB-2024, lot no 58160-0815-52). On an unknown date, the patient did not receive the 4th dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: Twinrix late 4th dose on the rapid schedule). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-MAY-2025 The pharmacist student reported that they have a patient who was on the rapid Twinrix dose schedule and she was getting her 4th dose and her Twinrix last dose was on 12th February 2024. Till the time of reporting, the patient did not receive 4th dose (booster) of Shingrix, which led to incomplete course of vaccination.